Researchers have found a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant in California, USA. This variant is more
Read more
syndrome
Neutralizing antibodies may be evolving to keep up with SARS-CoV-2 mutations
Viruses evolve under increased pressure, and new research from The Rockefeller University and University of Massachusetts Medical School in the
Read more
Optimized SARS-CoV-2 vaccine candidate could be less reactogenic, say researchers
A new study, released as a preprint on the bioRxiv* server, reports an optimized coronavirus disease 2019 (COVID-19) vaccine candidate,
Read more
Proteomics shows SARS-CoV-2 NSP7 and NSP8 forms stable dimeric unit
Coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has claimed over 2.6 million
Read more
In-licensed candidate may be an effective intervention for preterm infants with respiratory distress syndrome
The Lundquist Institute (TLI) and The Bill & Melinda Gates Medical Research Institute (Gates MRI) executed a license agreement for
Read more
A SARS-CoV-2 spike protein adjuvant vaccine candidate produces durable rapid protection in vivo
The ongoing coronavirus disease 2019 (COVID-19) pandemic has spurred intensive vaccine-related research. As yet, no targeted, safe and effective antivirals
Read more
Preclinical study finds immune benefit in unrefrigerated Soligenix coronavirus vaccines
Many vaccines have been developed to boost immunity against severe acute respiratory syndrome (SARS-CoV-2). However, a major concern during vaccine
Read more
Multiple COVID-19 variants of concern have reached Houston, Texas
New research by a team at Houston Methodist Hospital in the United States has modeled the aggressive genomic sequencing of
Read more
Coronavirus deranges the immune system in complex and deadly ways
There's a reason soldiers go through basic training before heading into combat: Without careful instruction, green recruits armed with powerful
Read more
Pfizer-BioNTech SARS-CoV-2 vaccine effective for wide range of Covid-19–related outcomes
The Pfizer-BioNTech mRNA vaccine was shown to be 95% effective in preventing severe COVID-19 infection in clinical trials. However, given
Read more